| Novo Nordisk Pharma AG - Insulin NovoNordisk Levemir 100 E/ml Penfill, Injektionslösung |
| 56370 | | 02 | | Insulin NovoNordisk Levemir 100 E/ml Penfill | | Injektionslösung | | A10AE05 | | Insulin detemir | | 30.04.2009 | | |
|
| Composition |
| insulinum detemirum 100 U., natrii chloridum, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 2.06 mg, phenolum 1.8 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Principe actif | Concentr. |
|---|
| Insulin Detemir | 100 U/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Insulin Detemir | 100 U |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Glycerol | | | | Metacresol | 2.06 mg/ml | conserv. | | Sodium Chloride | | | | Natrii Phosphates | | | | Phenol | 1.8 mg/ml | | | Zincum | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 5 x 3 ml | 46.55 | 67.05 | B | LS | Oui |
|
